Clinical Trial Update: Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis [Phase 2]

View source ↗

Summary

This phase 2 trial reports on the short-term safety and efficacy, and explores the mechanism of action, of apremilast in patients with moderate hidradenitis sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: M.B.A. van Doorn | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED